Publications from TNU

Sort by: Date | Author | Title

Sønderstrup, M., Batiuk, M. Y., Mantas, P., Tapias-Espinosa, C., Oliveras, I., Cañete, T., Sampedro-Viana, D., Brudek, T., Rydbirk, R., Khodosevich, K., Fernandez-Teruel, A., Elfving, B. & Aznar, S. (2023). A maturational shift in the frontal cortex synaptic transcriptional landscape underlies schizophrenia-relevant behavioural traits: A congenital rat model. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 74, 32-46. https://doi.org/10.1016/j.euroneuro.2023.05.001

Solskov, L., Løfgren, B., Pold, R., Kristiansen, S., Nielsen, T., Overstreet, D., Schmitz, O., Bøtker, H. E., Lund, S. & Wegener, G. (2009). Evaluation of the relation between hyperinsulinaemia and myocardial ischaemia-reperfusion injury in a rat model of depression. Clinical Science, 118(4), 259-67. https://doi.org/10.1042/CS20090108

Søgaard, H. J. & Bech, P. (2009). Psychiatric disorders in long-term sickness absence -- a population-based cross-sectional study. Scandinavian Journal of Public Health, 37(7), 682-9. https://doi.org/10.1177/1403494809344357

Søgaard, H. J. & Bech, P. (2009). Psychometric analysis of common mental disorders -- Screening Questionnaire (CMD-SQ) in long-term sickness absence. Scandinavian Journal of Public Health, 37(8), 855-63. https://doi.org/10.1177/1403494809344653

Søgaard, H. J. (2009). Choosing screening instrument and cut-point on screening instruments. A comparison of methods. Scandinavian Journal of Public Health, 37(8), 872-80. https://doi.org/10.1177/1403494809344442

Søgaard, H. J. & Bech, P. (2009). The effect on length of sickness absence by recognition of undetected psychiatric disorder in long-term sickness absence. A randomized controlled trial. Scandinavian Journal of Public Health, 37(8), 864-71. https://doi.org/10.1177/1403494809347551

Søgaard, H. J. & Bech, P. (2010). Predictive validity of common mental disorders screening questionnaire as a screening instrument in long sickness absence. Scandinavian Journal of Public Health, 38(4), 375-385. https://doi.org/10.1177/1403494809350520

Søgaard, H. J. & Bech, P. (2010). Compensating for non-response in a study estimating the incidence of mental disorders in long-term sickness absence by a two-phased design. Scandinavian Journal of Public Health, 38(6), 625-32. https://doi.org/10.1177/1403494810373673

Søgaard, H. J. & Pedersen, P. (2011). Non-participants in sickness absence studies show higher frequencies of mental disorders and faster return to work than participants. Poster session presented at Psykiatriens 6. Forskningsdag, Risskov, Denmark.

Søgaard, H. J. (2012). Undetected common mental disorders in long-term sickness absence. International Journal of Family Medicine, 2012, 474989. https://doi.org/10.1155/2012/474989

Søgaard, H. J. & Pedersen, P. (2012). Prevalence of common mental disorders among incident individuals on long-term sickness absence when compensating for non-participation. Psychology, 3(Special Issue), 818-824. https://doi.org/10.4236/psych.2012.329124

Søgaard, H. J. (2012). Variation in the effect of intervention studies in research on sickness absence. Open Access Journal of Clinical Trials.

Søgaard, H. J. & Bech, P. (2010). The effect of detecting undetected common mental disorders on psychological distress and quality of life in long-term sickness absence: a randomised controlled trial. Scandinavian Journal of Public Health, 38(8), 845-56. https://doi.org/10.1177/1403494810379292

Søgaard, H. J. (2008). Incidence of and Screening for Mental Disorders among Patients on continuous sick-leave for more than eight weeks.

Smith, D. F. (2002). Functional salutogenic mechanisms of the brain. Perspectives in Biology and Medicine, 45(3), 319-328.

Smith, D. F. (2001). Negative emotions and coronary heart disease: Causally related or merely coexistent? A review. Scand J Psychol, 42, 57-69.

Smith, D. F., Bender, D., Marthi, K., Cumming, P., Hansen, S. B., Peters, D., Nielsen, E. O., Scheel-Kruger, J. & Gjedde, A. H. (2001). Synthesis and evaluation of racemic [(11)C]NS2456 and enantiomers as selective serotonin reuptake radiotracers for PET. Nucl. Med. Biol., 28(3), 265-270.

Smith, D. F. & Geday, J. (2001). PET neuroimaging of clomipramine challenge in humans: focus on the thalamus. Brain Research, 892, 193-197.

Smith, D. F., Gee, A., Hansen, S. B., Moldt, P., Nielsen, E. O., Krüger, J. S., Ishizu, K., Sakoh, M., Østergaard, L., Poulsen, P. H., Bender, D. & Gjedde, A. H. (2001). Serotonin Release and Reuptake Studied by PET Neuroimaging Using Fenfluramine O Water, Oxygen, Fluorodeoxyglucose, CNS2381 and its Enantiomers in Living Porcine Brain. In Physiological Imaging of the Brain with PET (pp. 237-247)

Smith, D. F. & Rodell, A. (2003). Epilog: Descartes dilemma. En samtale ved frokostbordet. In På sporet af det indre liv. PET i Århus 1993-2003 (pp. 179-182). Forlaget Professionelle og Eksperimenterende Tekster, Århus.

Smith, D. F., Dyve, S., Minuzzi, L., Jakobsen, S., Munk, O. L., Marthi, K. & Cumming, P. (2006). Inhibition of [(11)C]mirtazapine binding by alpha(2)-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. Synapse, 59(8), 463-471.

Smith, D. F. & Jakobsen, S. (2007). Stereoselective neuroimaging in vivo. European Neuropsychopharmacology.

Smith, D. F., Stork, B. S., Wegener, G., Jakobsen, S., Bender, D., Audrain, H., Jensen, S. B., Hansen, S. B., Rodell, A. & Rosenberg, R. (2007). Receptor occupancy of mirtazapine determined by PET in healty volunteers. Psychopharmacology.

Smith, D. F., Jensen, P. N., Gee, A. D., Hansen, S. B., Danielsen, E., Andersen, F., Saiz, P. A. & Gjedde, A. (1997). PET neuroimaging with [11C]venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain. European Neuropsychopharmacology, 7(3), 195-200.

Smith, D. F., Gee, A. D., Hansen, S. B., Moldt, P., Nielsen, E. Ø., Scheel-Krüger, J. & Gjedde, A. (1999). Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain. European Neuropsychopharmacology, 9(4), 351-9.

Smith, D. F., Poulsen, P. H., Ishizu, K., Sakoh, M., Hansen, S. B., Gee, A. D., Bender, D. & Gjedde, A. (1998). Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain. Journal of Neuroscience Methods, 86(1), 17-23.

Smith, D. F., Hansen, S. B., Østergaard, L., Gee, A. D., Danielsen, E., Ishizu, K., Bender, D., Poulsen, P. H. & Gjedde, A. (2001). [14C]Serotonin uptake and [O-methyl-11C]venlafaxine kinetics in porcine brain. Nuclear Medicine and Biology, 28(6), 633-8. https://doi.org/10.1016/S0969-8051(01)00230-X

Smith, D. F., Bender, D., Marthi, K., Cumming, P., Hansen, S. B., Peters, D., Nielsen, E. O., Scheel-Krüger, J. & Gjedde, A. (2001). Synthesis and evaluation of racemic [(11)C]NS2456 and enantiomers as selective serotonin reuptake radiotracers for PET. Nuclear Medicine and Biology, 28(3), 265-70.

Smith, D., Hansen, S., Jakobsen, S., Bender, D., Audrain, H., Ashkanian, M., Stork, B., Minuzzi, L., Hall, H. & Rosenberg, R. (2008). Neuroimaging of mirtazapine enantiomers in humans. Psychopharmacology, 200, 273-279. https://doi.org/10.1007/s00213-008-1208-6

Smith, D. F., Hansen, S. B., Jakobsen, S., Bender, D., Audrain, H., Ashkanian, M., Stork, B. S. & Rosenberg, R. (2008). Regional binding potentials of [11C]mirtazapine enantiomers in human brain. European Neuropsychopharmacology, 18(S4), S260-S261.

Smith, D. F. & Jakobsen, S. (2009). Molecular tools for assessing human depression by positron emission tomography. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 19(9), 611-28. https://doi.org/10.1016/j.euroneuro.2009.04.005

Smith, D., Stork, B., Wegener, G., Ashkanian, M., Jakobsen, S., Bender, D., Audrain, H., Vase, K., Videbech, P. & Rosenberg, R. (2009). [(11)C]Mirtazapine binding in depressed antidepressant nonresponders studied by PET neuroimaging. Psychopharmacology, 206, 133-140. https://doi.org/10.1007/s00213-009-1587-3

Smith, D. F. & W. Miller, P. (2010). Challenges for PET Neuroimaging of Depressive Disorders. In C. M. Del-Ben (Ed.), Neuroimaging (pp. 71-90). Sciyo.

Smith, D. F., Bender, D. & Rosenberg, R. (2011). Antidepressant Receptor Occupancy of [11C] Mirtazapine in Humans. http://www.mindlab.au.dk/medias/media70.jpg

Smith, D. F. (2011). Early lithium research of Per Vestergaard as seen by a biopsychologist. In R. Rosenberg & P. Videbech (Eds.), Per Vestergaard og psykiatrien 1977 - 2011 (pp. 117-120)

Smith, D. F. & Gerdes, U. (2012). Meta-analysis on anxiety and depression in adult celiac disease. Acta Psychiatrica Scandinavica, 125(3), 189-93. https://doi.org/10.1111/j.1600-0447.2011.01795.x

Smith, D. F., Nødskov, H., Winterdahl, M., Lund, T. E., Han, Y., Zhao, J. & Zhijian, Y. (2011). Depression og funktionel hjernescanning i Nanjing og Århus. Poster session presented at Psykiatriens 6. Forskningsdag, Risskov, Denmark.

Smith, D. F., Marthi, K., Munk, O. L., Cumming, P., Hansen, S. B. & Jakobsen, S. (2006). PET neuroimaging of [11C]mirtazapine enantiomers in pigs. European Neuropsychopharmacology, 16(5), 350-7. https://doi.org/10.1016/j.euroneuro.2005.10.008

Smith, D. F. (2012). At være eller ikke at være: aktuelle udfordringer for hjernescanning af depression. Poster session presented at Psykiatriens 7. Forskningsdag, Risskov, Denmark.

Smith, D. F., Nødskov, H., Winterdahl, M. & Lund, T. E. (2013). Replication attempt to estimate depression severity by fuzzy logic analysis of emotion-focused fMRI. Journal of Magnetic Resonance Imaging, 37(2), 498-9. https://doi.org/10.1002/jmri.23833

Smith, D. F. (2013). Benefits of flavanol-rich cocoa-derived products for mental well-being: A review. Journal of Functional Foods, 5(1), 10-15. https://doi.org/10.1016/j.jff.2012.09.002

Smith, D. F. & Jakobsen, S. (2013). Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity. Frontiers in Psychiatry, 4, 8. https://doi.org/10.3389/fpsyt.2013.00008

Smith, D. F. (2013). Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk. Frontiers in Psychiatry, (18 June 2013).

Smith, A. A. A., Wohl, B. M., Kryger, M. B. L., Hedemann, N., Guerrero-Sanchez, C., Postma, A. & Zelikin, A. N. (2014). Macromolecular Prodrugs of Ribavirin: Concerted Efforts of the Carrier and the Drug. Advanced Healthcare Materials, 3(9), 1404-1407. https://doi.org/10.1002/adhm.201300637

Smith, D. F. (2014). Exploratory meta-analysis on deep brain stimulation in treatment-resistant depression. Acta Neuropsychiatrica (Print), 1-3. https://doi.org/10.1017/neu.2014.22

Smith, D. F., Dyve, S., Minuzzi, L., Jakobsen, S., Munk, O. L., Marthi, K. & Cumming, P. (2006). Inhibition of [11C]mirtazapine binding by alpha2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. Synapse, 59(8), 463-71. https://doi.org/10.1002/syn.20262

Smith, D. F. & Jakobsen, S. (2014). Minireview of Stereoselective Brain Imaging. Archives of Current Research International, 1(1), 1-16. Article ACRI.2014.001. https://doi.org/10.9734/ACRI/2014/14787

Smith, D. F. (2015). Gluten-free Diet And Psychic Depression i Celiac Disease. In Gluten-Free Diets: Food Sources, Role in Celiac Disease and Health Benefits (pp. 51-62). Nova Science Publishers. https://www.novapublishers.com/catalog/product_info.php?products_id=54093&osCsid=c9b3d70986ff925a29b5ad80f8762a1f

Smith, K. L., Cunningham, J. I., Eyerman, D. J., Dean, R. L., Deaver, D. R. & Sanchez, C. (2019). Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. Neuropharmacology, 146(March), 316-326. https://doi.org/10.1016/j.neuropharm.2018.11.015

Displaying results 351 to 400 out of 2448

Revised 06.02.2023

Karen Jul Madsen